Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Assembly Biosciences (ASMB) Profit After Tax: 2015-2025

Historic Profit After Tax for Assembly Biosciences (ASMB) over the last 9 years, with Sep 2025 value amounting to -$9.2 million.

  • Assembly Biosciences' Profit After Tax rose 4.34% to -$9.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$38.5 million, marking a year-over-year increase of 5.53%. This contributed to the annual value of -$40.2 million for FY2024, which is 34.38% up from last year.
  • As of Q3 2025, Assembly Biosciences' Profit After Tax stood at -$9.2 million, which was up 9.83% from -$10.2 million recorded in Q2 2025.
  • Over the past 5 years, Assembly Biosciences' Profit After Tax peaked at -$8.8 million during Q1 2025, and registered a low of -$60.3 million during Q4 2021.
  • For the 3-year period, Assembly Biosciences' Profit After Tax averaged around -$11.8 million, with its median value being -$10.3 million (2024).
  • As far as peak fluctuations go, Assembly Biosciences' Profit After Tax crashed by 461.45% in 2021, and later surged by 52.10% in 2024.
  • Quarterly analysis of 4 years shows Assembly Biosciences' Profit After Tax stood at -$60.3 million in 2021, then reached -$11.0 million in 2023, then rose by 5.72% to -$10.3 million in 2024, then increased by 4.34% to -$9.2 million in 2025.
  • Its last three reported values are -$9.2 million in Q3 2025, -$10.2 million for Q2 2025, and -$8.8 million during Q1 2025.